DMAC
DiaMedica Therapeutics Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
DiaMedica Therapeutics (DMAC) Stock: Buy, Sell, or Hold?
$9.33
-0.33 (-3.42%)
âŧ
5d:
+3.21%
30d:
+21.8%
90d:
+39.67%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
48/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$8.03 â $9.60
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-12.5x
Next 12M consensus est.
Wall Street Target
$15.50
+66.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.96 / $11.00
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: DMAC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When DMAC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: DMAC is currently trading at $9.33, which is considered slightly high relative to its 30-day fair value range of $8.03 to $9.60.
Technical Outlook: Technically, DMAC is in a uptrend. Immediate support is located at $8.96, while resistance sits at $11.00. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: DMAC scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.50 (+66.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DMAC is in a uptrend. Immediate support is located at $8.96, while resistance sits at $11.00. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: DMAC scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.50 (+66.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.03 -
$9.60
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Trading Range & Key Levels
30-Day Trading Range
$8.03 -
$9.60
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$0.89
(9.6%)
Support Level
$8.96
Resistance Level
$11.00
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 66.1% below Wall St target ($15.50)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-12.48
Wall Street Target
$15.50
(+66.1%)
Share DMAC Analysis
Share this live DMAC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DMAC)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
SCAG announced a strategic cooperation agreement with China Huaye Group. The agreement is bullish for SCAG as it expands their reach into the Chinese market.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:26 PM ET
Data refreshes hourly during market hours. Next update: 8:26 PM
Data refreshes hourly during market hours. Next update: 8:26 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DMAC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
ABVX
Abivax SA American DeposâĻ |
STRONG BUY
12 analysts |
$164 | 64 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DMAC Research Pages
